Trends of Therapy in the Treatment of Asthma

Overview

Journal Ther Adv Respir Dis

Publisher Sage Publications

Specialties Pharmacology
Pulmonary Medicine

Date 2023 Mar 21

PMID 36942731

Authors

Xiaodi Lv

Zhen Gao

Weifeng Tang

Jingjing Qin

Wenqian Wang

Jiaqi Liu

Mihui Li

Fangzhou Teng

La Yi

Jingcheng Dong

Ying Wei

Affiliations

Soon will be listed here.

Abstract

Background: To better understand the development of therapy for asthma, grasp the core paradigm associated with the transformation of cognition of asthma treatment and asthma, explore potential and effective therapies for asthma, discover new biomarkers and mechanisms related to asthma treatment, find novel targets for anti-asthma drugs, and predict the future trends of asthma therapy, we used a bibliometric analysis to research articles related to the therapies for asthma published from 1983 to 2022.

Methods: A comprehensive search was conducted to analyze the articles associated with therapy for asthma with the help of the Web of Science Core Collection (WOSCC) database from January 1, 1983 to August 14, 2022. The CiteSpace 6.1.R2 software and VOS viewer 6.1.8 software were utilized to analyze the overall structure of the network, network clusters, links between clusters, key nodes, and pathways.

Results: A total of 3902 publications related to therapies on asthma were published in 3211 academic journals by a total of 14,655 authors in 3476 organizations from 87 countries or regions from 1983 to 2022. The United States published the most articles ( = 1143), followed by England ( = 574) and China ( = 405). However, the centrality of China was 0.4, higher than the United States (centrality = 0.16) and Singapore (centrality = 0.11). Akdis Cezmi published the most papers. published the most studies on therapies for asthma. Asthma was the most frequent keyword ( = 594). The betweenness centrality value of keywords that were greater than 0.1 included airway inflammation (centrality = 0.22), double blind (centrality = 0.18), asthma (centrality = 0.17), inflammation (centrality = 0.12), and inhaled corticosteroid (centrality = 0.11).

Conclusions: The results from this biometric review provide insight into the development of therapy for asthma, the paradigm of recognition of this field, the approach of discovering new targets, exploration and combination of new mechanisms, and the frontier trend of this field in future.

Citing Articles

Mendelian randomization analysis and molecular mechanism study of childhood asthma and obstructive sleep apnea.

Wang X, Zhang L, Chen H, Tian T, Wu L, Huang Y Hum Genet. 2025; .

PMID: 40029375 DOI: 10.1007/s00439-025-02734-0.

Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis.

Leng X, Wei X, Wang J, Yao X, Zhang M, Sun D Front Microbiol. 2025; 15():1491731.

PMID: 39834376 PMC: 11743947. DOI: 10.3389/fmicb.2024.1491731.

Global trends and prospects related to macrophage in chronic kidney disease: a bibliometric analysis.

Hu Y, Wang Y, Hong H, Chen Y, Zhou Q, Zhu G Ren Fail. 2024; 46(2):2423846.

PMID: 39572163 PMC: 11583328. DOI: 10.1080/0886022X.2024.2423846.

Global tendency and frontiers of research on pertussis from 2000 to 2023: A bibliometric and visual analysis.

Wang H, Liu X, Cao X, Liu J, Li W Hum Vaccin Immunother. 2024; 20(1):2392334.

PMID: 39238254 PMC: 11382716. DOI: 10.1080/21645515.2024.2392334.

Probiotic nucleotides increase IL-10 expression in airway macrophages to mitigate airway allergy.

Xue J, Liu Z, Xie B, Dong R, Wu J, Wu Y Inflamm Res. 2024; 73(11):1919-1930.

PMID: 39235607 DOI: 10.1007/s00011-024-01940-2.

References

Leung D, Sampson H, Yunginger J, Burks Jr A, Schneider L, Wortel C . Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003; 348(11):986-93. DOI: 10.1056/NEJMoa022613. View

Castro M, Corren J, Pavord I, Maspero J, Wenzel S, Rabe K . Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma. N Engl J Med. 2018; 378(26):2486-2496. DOI: 10.1056/NEJMoa1804092. View

Cox L, Linnemann D, Nolte H, Weldon D, Finegold I, Nelson H . Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006; 117(5):1021-35. DOI: 10.1016/j.jaci.2006.02.040. View

Asher M, Garcia-Marcos L, Pearce N, Strachan D . Trends in worldwide asthma prevalence. Eur Respir J. 2020; 56(6). DOI: 10.1183/13993003.02094-2020. View

Nair P, Pizzichini M, Kjarsgaard M, Inman M, Efthimiadis A, Pizzichini E . Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009; 360(10):985-93. DOI: 10.1056/NEJMoa0805435. View

Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss D . Neutrophil extracellular traps kill bacteria. Science. 2004; 303(5663):1532-5. DOI: 10.1126/science.1092385. View

Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

Barnes N, Pavord I, Chuchalin A, Bell J, Hunter M, Lewis T . A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy. 2011; 42(1):38-48. DOI: 10.1111/j.1365-2222.2011.03813.x. View

Liang Y, Li Y, Zhao J, Wang X, Zhu H, Chen X . Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017; 10:951-964. PMC: 5411170. DOI: 10.2147/JPR.S132808. View

10.

Aaron S, Boulet L, Reddel H, Gershon A . Underdiagnosis and Overdiagnosis of Asthma. Am J Respir Crit Care Med. 2018; 198(8):1012-1020. DOI: 10.1164/rccm.201804-0682CI. View

11.

Nair P, Gaga M, Zervas E, Alagha K, Hargreave F, OByrne P . Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy. 2012; 42(7):1097-103. DOI: 10.1111/j.1365-2222.2012.04014.x. View

12.

Holze C, Michaudel C, Mackowiak C, Haas D, Benda C, Hubel P . Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat Immunol. 2017; 19(2):130-140. PMC: 5786482. DOI: 10.1038/s41590-017-0013-y. View

13.

Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D . JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Gastroenterology. 2017; 154(5):1480-1493. PMC: 5880694. DOI: 10.1053/j.gastro.2017.12.004. View

14.

Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B . Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016; 388(10039):31-44. DOI: 10.1016/S0140-6736(16)30307-5. View

15.

Khan M, Assiri A, Broering D . Complement mediators: key regulators of airway tissue remodeling in asthma. J Transl Med. 2015; 13:272. PMC: 4544802. DOI: 10.1186/s12967-015-0565-2. View

16.

Poon A, Eidelman D, Laprise C, Hamid Q . ATG5, autophagy and lung function in asthma. Autophagy. 2012; 8(4):694-5. DOI: 10.4161/auto.19315. View

17.

Yuan H, Lu J, Wang X, Lv Z, Li B, Zhu W . The Effects of a Transgelin-2 Agonist Administered at Different Times in a Mouse Model of Airway Hyperresponsiveness. Front Pharmacol. 2022; 13:873612. PMC: 9243334. DOI: 10.3389/fphar.2022.873612. View

18.

Berry M, Hargadon B, Shelley M, Parker D, Shaw D, Green R . Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006; 354(7):697-708. DOI: 10.1056/NEJMoa050580. View

19.

Keeley D, Silverman M . Issues at the interface between primary and secondary care in the management of common respiratory disease.2: Are we too ready to diagnose asthma in children?. Thorax. 1999; 54(7):625-8. PMC: 1745508. DOI: 10.1136/thx.54.7.625. View

20.

Delettre C, Yuste V, Moubarak R, Bras M, Lesbordes-Brion J, Petres S . AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with potential pathological relevance in human cancer. J Biol Chem. 2005; 281(10):6413-27. DOI: 10.1074/jbc.M509884200. View